Search

I haven’t added any new stocks for a while because we’ve already got 30 stocks in the portfolios. Our current stocks have mostly been rising: the good, the bad and the ugly. However, I always have a good list of stocks that are waiting in the wings, so I really should rotate into some of them.

U.S. stocks delivered great performance in January and are now taking a breather. As such, I expect the S&P 500 index to trade between 2625 and 2825 for a while. The trading range might end up being a little higher or a little lower, but for now, a repetition of the trading range that took place between late October through early December seems most likely to occur. I anticipate that the market indexes will continue advancing later this year.

The market continues to chop around, with forays into new-high ground inviting plenty of sellers and sharp dips quickly attracting bargain-hunting buyers. We are seeing more set-ups out there, which is a good sign—if the market does kick into gear, there should be some solid leadership. However, until then, this is about as neutral and choppy an environment as we can remember. That doesn’t mean you shouldn’t take any action (this isn’t 2008!), but it’s best to wait for the market to show some bullish action before getting heavily invested. Patience and cash are your allies today.

This week’s list is the first in a while that has a growth tilt to it; there are still some cheap, stable-type stocks, but also some real potential leaders of the next advance. Our favorite is Arris Group (ARRS), which has excellent growth prospects, a huge backlog and a nice-looking launching pad.

Stock Name	Price	Buy Range	Loss Limit
WhiteWave Foods (WWAV)	0.00	29.5-31	26.5-27
Vipshop Holdings (VIPS)	14.25	150-160	138-140
Trinity Industries (TRN)	0.00	78-82	73-74
Rice Energy (RICE)	0.00	29.5-31	27.5-28
Pacira Biosiences (PCRX)	54.85	72.5-75.5	67-68
InterMune (ITMN)	0.00	36-38	33-34
Gilead Sciences (GILD)	75.10	79-83	75.5-76.5
CBRE Group (CBG)	0.00	28-29	26-26.5
Arris Group (ARRS)	0.00	29-31	26.5-27.5
Apple (AAPL)	248.94	580-600	530-540

It’s been a fun and fruitful 2013, and we hope you were able to snag a few winners this year. That said, while we enjoy reviewing this past year as much as anyone, our focus is on the present and the future—so far, the overall market is in fine shape, though intriguingly, despite what is supposed to be a quiet time of year, we’ve seen a few sharp selloffs among growth stocks during the past couple of days. Of course, there are always lots of crosscurrents at year-end, but it’s imperative to keep your eyes open, pick your spots on the buy side and have some stops in place should the selling spread. Right now, though, we’re sticking with our lean bullish stance and will see how things shake out when the calendar turns.
This week’s list is very diversified, with many different industries represented. Our favorite of the week is Salix Pharmaceuticals (SLXP), a solid growth firm whose recent buyout of Santarus could be a gamechanger.

Stock Name	Price	Buy Range	Loss Limit
United States Steel Corporation (X)	0.00	28-30	26-26.5
Valero Energy (VLO)	97.40	46-47	42-43
United Therapeutics (UTHR)	0.00	105-112	97-100
Seagate Technology (STX)	0.00	53-55	49-50
Salix Pharmaceuticals (SLXP)	0.00	86-90	81-82
Royal Caribbean Cruises (RCL)	0.00	45-47	39-40
NXP Semiconductors (NXPI)	0.00	43-45	40-41
Legg Mason Inc. (LM)	37.44	40-42	38-39
Facebook, Inc. (FB)	0.00	52.5-55.5	48-49
Conn’s Inc. (CONN)	0.00	74-78	68.5-69.5

After a great three-month advance, last week’s big distribution on Wednesday and Thursday is a shot across the bow; more than likely we’ve seen some type of short-term peak, and experience tells us to expect some follow-on selling in the near-term (we saw some today after a big upmove at the open). However, when looking at the intermediate-term, the trend remains up, which is why we’re keeping our Market Monitor in bullish territory. Thus, it’s prudent to cut back on your losers and laggards and hold a little cash, but you should stick with your best performers. And, when it comes to new buying, you can be a bit more discerning, buying on weakness and waiting for your pitch.

This week’s list, frankly, has more great-looking charts than we expected to see, albeit from some less-sexy sectors. Our favorite of the week is AECOM Technology (ACM), a good-sized construction firm that’s shown outstanding accumulation. Look to get in on weakness.

Stock Name	Price	Buy Range	Loss Limit
State Street (STT)	79.42	54-56	-
RockTenn (RKT)	0.00	82-85	-
Norwegian Cruise Lines (NCLH)	0.00	28.5-30	-
Lions Gate Entertainment Corp. (LGF)	0.00	19-20	-
Kansas City Southern (KSU)	176.54	95-97	-
Computer Sciences (CSC)	0.00	45-47	-
Cabot Oil & Gas (COG)	0.00	56-58	-
BlackRock (BLK)	0.00	230-240	-
Aruba Networks (ARUN)	0.00	23.5-25	-
Aecom Technology (ACM)	0.00	28.5-30	-

When we moved our Market Monitor into bullish territory back on December 10 we had no idea how much strength would develop in the market. It’s been a great run! Today many stocks finally hit a bit of resistance as profit taking showed up; in the short-term, it’s possible the long-awaited pullback could be starting. But, while potholes will come, the evidence doesn’t point to a major correction; most stocks and sectors have just leapt out of 12- to 24-month bases with great power, and many measures of the broad market confirm the underlying strength. Bottom line: while you shouldn’t throw your money into stocks willy-nilly or ignore your sell rules, you should remain bullish and give your best performers a chase to continue higher.
This week’s list reflects the encouraging earnings season thus far; many stocks on the list have recently shot ahead after bullish results and outlooks. Our favorite of the week is Cree Inc. (CREE), the best way to play the growth in LED lighting. Its turnaround plan is working and the stock looks like a new leader.

Stock Name	Price	Buy Range	Loss Limit
Tesla, Inc. (TSLA)	818.87	35.5-37.5	-
Terex (TEX)	0.00	30-32	-
RockTenn (RKT)	0.00	75-78	-
Oshkosh (OSK)	95.04	38-40	-
Netflix, Inc. (NFLX)	423.92	155-165	-
Mohawk Industries (MHK)	0.00	98-102	-
Kansas City Southern (KSU)	176.54	90-93.5	-
Delta Air Lines (DAL)	54.28	13-14	-
Credit Suisse (CS)	0.00	27-29	-
Cree, Inc. (CREE)	67.96	39.5-42	-

Market performance for the rest of the year will depend upon a full recovery brought on by the vaccines the removal of lockdowns and restrictions. If that doesn’t happen, look out. But I’m confident it will.

Of course, the pricey market indexes don’t apply to many individual stocks. Some stocks are very overvalued while others remain undervalued. At this point, the more conservative play is to target stocks with cheap valuations to buy, especially while many of those bargain stocks also have newfound momentum.



In this issue, I highlight a blue-chip energy stock. It sells at a dirt-cheap valuation while paying a high and safe dividend. It also has strong momentum ahead of what is likely to be a year of vastly improved profits.

While the direction of the market is highly unpredictable in the short term, it’s a safe bet that this economy will continue to recover after the covid recession. It is also highly likely that interest rates will continue to rise.

Interest rates tend to move higher as the economy emerges from recession and gains traction. It’s already happening. The benchmark 10-year Treasury bond yield has already risen sharply this year. Yet, rates are still well below pre-pandemic levels, and the economy is about to ignite. There will also be trillions in stimulus dollars causing inflationary pressures and upward pressure on rates.



Certain dividend stocks and income paying securities endure despite rising rates. And certain special securities can actually thrive. In this issue, I highlight an investment that loves rising rates. In fact, profits increase directly as a result. The stock pays a stratospheric 8.4% yield and pays dividends every month.



In this issue, I highlight an investment that loves rising rates. In fact, profits increase directly as a result. The stock pays a stratospheric 8.4% yield and pays dividends every month.

The long-awaited pullback appears to have arrived, with fears and uncertainty surrounding the coronavirus and its impact on economic growth bringing out the sellers; our Cabot Tides, in fact, are now on the fence. In the near-term, the odds favor some more pain being dished out, not necessarily because of the virus, but as the market consolidates its strong four-month advance. Big picture, though, this is still a bull market, so while we’ve trimmed a bit, we’re aiming to hold our strong, profitable stocks, thinking higher highs are likely once this pullback does its work.

In the Model Portfolio, we took partial profits on DocuSign and ProShares S&P 500 Fund earlier this week, which lifted our cash position to around 20%. And from here, we’ll just take it as it comes, as we explain in tonight’s issue.

While everyone is focused on the near-term risks and inconveniences of this pandemic, lasting changes are being forged. Major events have a way of reshaping the American psyche and changing behavior. This pandemic ordeal is forever altering aspects of our culture, creating an a unique opportunity for investors.
In this month’s issue I highlight a stock that directly benefits from the fact that people will continue to do more things from home than they did before the pandemic. It sells popular packaged food brands. Business is booming and should stay good for a long time.


A former slow-growth stock is being transformed into a fast-growing, high-yielding investment that is ideal to hold through the crisis and beyond. Investors are just beginning to realize the opportunity. But you can still get in cheap.

At a new all-time high, this is a tough market to navigate. Sure, the market could stay good for a while. But at this late-stage of the bull market and recovery, how much is left in the tank?

It’s hard to muster the enthusiasm to take on risk to get the last drop of this late stage bull market before the next downturn. While defensive stocks make a lot of sense here, most are very expensive. But there is one place where stock prices are still cheap, value stocks.

Investors have been rotating toward the long-neglected value stocks and they are starting to perk up. These stocks represent a way to get bargains in an expensive market as well as protection from the next downturn. And some stocks even have momentum.

In this issue, I highlight a stock that is one of the best healthcare companies in the world that is perfectly positioned ahead of the world’s most pronounced megatrend. It also offers great value in an expensive market and has recently found upward momentum.

There is a brand new industry just coming of age.

New industries only come along once in a while and they almost always present an array of investments that will be superstars of tomorrow. We dream of going back in time and buying Microsoft (MSFT) or Starbucks (SBUX) or Netflix (NFLX) when they were new, upstart companies. But we might get another bite of a similar apple in 2020.

It’s a New Year, but the market’s evidence remains unchanged--big picture, it’s a strong bull market, though short-term risks are rising, telling us to be choosy on the buy side and to hold a chunk of cash. That said, we’re still holding on tightly to our winners and think a few of our current stocks can enjoy sustained runs from here.

In tonight’s issue, we write about how many stocks that have recently had big moves actually look to be early in their overall advances; pullbacks, in other words, should offer buying opportunities. We also dive into our stocks and write about a couple of names on our watch list could be our next buys.

Surprisingly good earnings reports boosted many stocks in our portfolios in recent weeks, and the same factor has turned the trends of the major indexes favorable; it’s good to be invested.
But we must never grow complacent, and one way I reduce risk in the Cabot Stock of the Week portfolio is by diversifying by both industry group and investment style.
This week’s recommendation, for example, is a growth stock; it was originally recommended by Mike Cintolo in Cabot Top Ten Trader. But it’s in an industry that’s generally regarded as conservative, and where stocks are usually appraised on a value basis. I think you’ll enjoy it.

September is living up to its reputation as a tricky month, with lots of volatility among leading stocks and rotation and news-driven moves on a day-to-day basis. Still, just going with the evidence, the trends of the major indexes and most stocks are up, so I remain bullish. That said, finding stocks early in their overall uptrends that aren’t obvious to the crowd is vital—tonight’s Stock of the Week fills the bill, blasting off three weeks ago after a 14-month correction and consolidation.

Thank you for subscribing to the Cabot Undervalued Stocks Advisor. We hope you enjoy reading the February 2022 issue.



Word puzzle Wordle is the latest craze, but it isn’t the most popular parlor game. This title is held by “What Is Russian President Vladimir Putin Going to Do With Ukraine?”



We provide our theory which is not found anywhere else yet could readily explain his motivation. Related to this crisis, we move shares of ConocoPhillips (COP) from Buy to Hold, as they have surged above our recently raised 89 price target.



Please feel free to send me your questions and comments. This newsletter is written for you and the best way to get more out of the letter is to let me know what you are looking for.



I’m best reachable at Bruce@CabotWealth.com. I’ll do my best to respond as quickly as possible.

The world has clearly changed in the past two weeks. We see an exceptionally wide range of possible outcomes, which makes predictions about the future (already a low success rate endeavor) basically futile. We offer our timeless investing advice that can be readily applied in such situations.

In the letter, we also provide updates on all of our Recommended Stocks.

The explosive growth of artificial intelligence, electric cars, and manufacturing is causing an explosion in the demand for electricity in this country.

After nearly two decades of stagnant growth, electricity demand is expected to soar in the years ahead. This year alone, electricity demand is growing 81% more than it did last year. Electricity demand is expected to grow at nearly twice the past rate for the rest of this decade.

The new demand transforms certain previously stodgy and boring utility stocks into growth investments.

In this issue I highlight one of the very best and fastest-growing electricity producers in the country. This company is in an ideal position to benefit from the increasing electricity demand from data centers and other sources. AI may be the cutting edge of technological innovation. But it doesn’t work without electricity. While most investors are running around chasing the same AI stocks, we can reap the rewards of the tremendous new opportunity from Thomas Edison’s invention.

The S&P spent most of the first half of July setting new highs. But that changed last week. The technology sector sold off on news of new AI chip export restrictions to China. The S&P fell about 2% for the week, giving up most of the gains for July. It may be a blip. It probably is. But the market is high, and stocks showed vulnerability to bad headlines.

A flatter or down market going forward makes income more valuable. The cash register continues to ring regardless of short-term market gyrations. At the same time, many income stocks are still cheap, and interest rates are likely to trend lower from here.

Some of the very best income stocks are in the energy sector. After recent price shocks and other problems in the energy sector, investors are coming around to realizing energy is a strong business that isn’t going anywhere for a long time.

In this issue, I highlight one of the best natural gas companies on the market. It is a newly formed company in the business of exporting abundant and cheap American natural gas overseas. It’s big business. In a short time, this company has become one of the world’s biggest natural gas exporters.